OK432 (Picibanil) in the Treatment of Lymphatic Malformations
Public ClinicalTrials.gov record NCT03427619. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Open Label Study to Evaluate the Efficacy and Safety of OK-432 Immunotherapy in Individuals With Lymphatic Malformations
Study identification
- NCT ID
- NCT03427619
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Richard JH Smith
- Other
- Enrollment
- 275 participants
Conditions and interventions
Conditions
Interventions
- OK432 Drug
Drug
Eligibility (public fields only)
- Age range
- 6 Months to 17 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 4, 2005
- Primary completion
- Apr 29, 2018
- Completion
- Apr 29, 2018
- Last update posted
- Nov 22, 2021
2005 – 2018
United States locations
- U.S. sites
- 14
- U.S. states
- 13
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rady Children's Hospital & Health Center San Diego | San Diego | California | 92123 | — |
| The Children's Hospital of Denver | Denver | Colorado | 80218 | — |
| Children's National Medical Center | Washington D.C. | District of Columbia | 20010 | — |
| All Children's Hospital | St. Petersburg | Florida | 33701 | — |
| Richard Smith, MD | Iowa City | Iowa | 52242 | — |
| Spectrum Health-SHMG Ear, Nose, & Throat | Grand Rapids | Michigan | 49546 | — |
| Children's Hospitals & Clinics of Minnesota - Minneapolis | Minneapolis | Minnesota | 55404 | — |
| SUNY Health Science Center | Syracuse | New York | 13210 | — |
| Oregon Health Sciences University | Portland | Oregon | 97239 | — |
| Vanderbilt University Hospital | Nashville | Tennessee | 37232 | — |
| Children's ENT of Houston | Houston | Texas | 77030 | — |
| Children's Hospital of the Kings Daughter | Norfolk | Virginia | 23507 | — |
| University of Wisconsin Hospital & Clinic | Madison | Wisconsin | 53279 | — |
| Children's Hospital of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03427619, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 22, 2021 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03427619 live on ClinicalTrials.gov.